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OBJECTIVES: Although routinely collected data might have
some biases compared to professional registries or medical trials,
a health care ﬁnancing agency is interested in these administra-
tive date, because the ﬁnancing of health care institutions is
based on these administrative data. The purpose of this study
was to analyse the seasonal occurrence of acute myocardial
infarction (AMI) during the year on an administrative dataset.
METHODS: Data derive from the database of the National
Health Insurance Fund Administration, the one and only health
care ﬁnancing agency in Hungary, containing routinely collected
ﬁnancial data for the year 2002. Patients were selected with AMI
diagnosis with the I21 and I22 codes of the International Clas-
siﬁcation of Diseases (ICD), admitted to acute care hospitals in
2002. We extracted the time of hospital admission from hospi-
tal records and patients having more AMI during the year were
counted again. Our study provides a nation wide coverage of
Hungary for 2002. We calculated the average number of AMI
cases (incidence) per month with 95% conﬁdence interval. Sta-
tistical analysis as one-way analysis of variance (ANOVA) was
carried out with SPSS 14.0 for Windows. RESULTS: Altogether
N = 16,418 patients were included into the analysis. The daily
number of patient with AMI diagnosis proved to be the lowest
in July and August with average 38–39 cases per day. The highest
incidence was observed in March, April and May with an
average incidence of 49, 51, 49 cases per day respectively. Sta-
tistical analysis resulted in F = 4744 which is highly signiﬁcant
(p < 0.001) value. CONCLUSION: The occurrence of AMI
showed highly signiﬁcant seasonal variations within the year
2002 on our nationwide dataset. We emphasize the role of large
administrative databases in order to analyse “real word” data.
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OBJECTIVES: To assess the prevalence of metabolic syndrome
in an urban, high risk, predominantly African American hyper-
tensive population. METHODS: The study is part of the NHLBI
U01 grant “Baltimore Partnership Programs to Reduce Cardio-
vascular Disparities”. Risk factors for metabolic syndrome were
assessed at baseline, and include risk factors of abdominal
obesity (BMI °Y´ 30), high triglycerides (triglycerides °Y´ 150
mg/dL), low HDL cholesterol (HDL < 40 mg/dL in men, or HDL
< 50 mg/dL in women), elevated blood pressure (BP °Y´ 130/85
mmHg), and elevated fasting glucose (blood glucose °Y´ 100
mg/dL) ¨C per American Diabetes Association criteria. We
assessed the number of patients with risk factors for metabolic
syndrome across race (Black vs. White patients) and gender, and
compared the average values of above indexes with metabolic
syndrome criteria. RESULTS: Out of a 321 patients, there were
17 white women, 17 white men, 191 black women and 96 black
men. By racial and gender groups, 4 White women (23.5%), 7
White men (41.2%), 33 Black women (17.3%) and 28 Black
men (29.2%) had 3 or more risk factors for Metabolic Syn-
drome. On average, study subjects are higher in BMI, blood
glucose level, blood pressures and HDL, and lower in triglyc-
erides level when compared with Metabolic Syndrome Criteria.
Black patients have higher BMI, systolic blood pressure, and
HDL and lower in triglycerides levels than their matched white
patients, however blood glucose levels are higher among whites.
Women have higher BMI and HDL, and lower blood glucose and
triglycerides levels than men. The differences are statistically sig-
niﬁcant (P < 0.05). CONCLUSION: Risk factors for metabolic
syndrome are highly prevalent in this urban high risk popula-
tion. Based on ADA criteria, black patients and women have
more risk factors for metabolic syndrome than whites and men,
respectively.
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OBJECTIVES: Although routinely collected data might have
some biases compared to registries or medical trials, a health care
ﬁnancing agency is interested in these administrative data,
because the ﬁnancing of health care institutions is based on these
“real word” data. The purpose of this study was to analyse the
1 year survival rate after acute myocardial infarction (AMI)
according to the type of hospitals. METHODS: Data derive from
the database of the National Health Insurance Fund Adminis-
tration (OEP), the only health care ﬁnancing agency in Hungary,
containing routinely collected ﬁnancial data for the year 2004.
Patients were selected with AMI diagnosis with the I21 and I22
codes of the International Classiﬁcation of Diseases (ICD),
admitted to acute care hospitals in 2004. Statistical analysis was
carried out with SPSS 14.0 for Windows. We created Kaplan-
Meier survival curves and calculated chi-square values (Mantel-
Cox log rank test). RESULTS: Altogether N = 16,451 patients
were included into the analysis. We found the highest survival
rates at universities (80.5%, N = 2224) and national medical
institutes (81.6%, N = 904). The city hospitals (71.7%, N =
5216), county hospitals (69.5%, N = 5221) and the hospitals of
Budapest (68.1%, N = 2780) had similar survival rates. Some
special hospitals had the lowest (56.6%) survival rate, but the
number of patients (N = 106) was very low. The log rank test
resulted in a chi-square value of 168.711 with 5 degree of
freedom resulting in a signiﬁcant difference (P < 0.001). The
average age of patients was the lowest at universities but the dif-
ference was not statistically signiﬁcant. CONCLUSION: The
survival of patients depends on the type of hospital. We empha-
size the role of large administrative databases in order to analyse
“real word” data.
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OBJECTIVES: The use of Nonsteroidal Anti-Inﬂammatory
Drugs (NSAIDs) has been associated with increased blood pres-
sure and hypertension. However, less is known about the risk of
hypertension associated with celecoxib, the only COX-2 selec-
tive inhibitor (coxib) available in the US market, in a real world
setting. The objective of this study is to compare the risk of inci-
